Key Highlights
- Krishna Institute of Medical Sciences Limited (NSE: KIMS) shares declined nearly 4% on Tuesday.
- Q1 FY27 operating revenue increased 35.3% year-on-year to ₹1,179.5 crore.
- Consolidated net profit declined 47.2% to ₹41.5 crore.
- EBITDA rose 16% year-on-year, while margins softened to 18.9%.
- Hospital network expanded to 7,459 operational beds.
- Investors remained cautious over near-term profitability despite strong revenue growth.
Why Did KIMS Shares Decline Even After Posting Robust Revenue Growth?
Krishna Institute of Medical Sciences Limited (NSE: KIMS), one of India's leading multi-specialty hospital chains, remained under pressure after announcing its Q1 FY27 financial results. Although the company delivered healthy double-digit revenue growth supported by rising patient volumes, the stock declined during the trading session as investors reacted to the sharp decline in quarterly profit. The market appeared to focus on the impact of expansion-related expenses, which weighed on earnings despite continued business growth.
Expansion Strategy Continued to Drive Revenue While Pressuring Profit Margins
KIMS reported revenue from operations of ₹1,179.5 crore for the June quarter, representing a 35.3% year-on-year increase from ₹871.6 crore in the corresponding quarter last year. The growth was supported by higher occupancy levels, increased patient volumes and the addition of new hospital capacity across its network.
However, consolidated net profit declined 47.2% year-on-year to ₹41.5 crore compared with ₹78.6 crore in the previous year's quarter. Operating EBITDA increased 16% to ₹223.4 crore, although EBITDA margins moderated to 18.9% from 22.1% due to higher operating expenses associated with recently commissioned facilities. Management continued to invest in future capacity expansion, taking the total operational bed count to 7,459 as of June 30, 2026.
Market Focus Shifts Towards Long-Term Capacity Expansion
The company's aggressive expansion strategy remains one of the primary long-term growth drivers. While newly added hospitals and infrastructure have temporarily increased operating costs, these investments are expected to support future patient volumes and revenue generation. Investors are likely to monitor the pace at which new facilities mature and contribute to profitability over the coming quarters.
Technical Indicators Reflect Short-Term Weakness Following Earnings
Krishna Institute of Medical Sciences Limited (NSE: KIMS) traded near ₹788.85 after opening at ₹801.35 and touching an intraday high of ₹822.90. The stock slipped below its 50-day Simple Moving Average of ₹793.76 during the session, indicating some near-term weakness following the earnings announcement. The 14-day Relative Strength Index stood near 46.21, suggesting neutral momentum after the recent decline.
Important Price Levels Traders Are Monitoring
Immediate support is placed near ₹788.50, followed by ₹775.00 if selling pressure continues. On the upside, resistance is seen around ₹822.90, while a sustained move above this level could improve the near-term technical outlook.
What Could Influence KIMS Shares Going Forward?
Future performance will depend on patient volume growth, occupancy improvement across newly commissioned hospitals, margin recovery, cost optimisation and the successful integration of expansion projects. Healthcare demand and execution efficiency will also remain key drivers for future earnings.
Market Takeaway
Krishna Institute of Medical Sciences Limited (NSE: KIMS) delivered another quarter of strong revenue growth driven by expanding healthcare capacity and rising patient volumes. However, higher expansion-related costs weighed on profitability, resulting in a weaker market reaction. Investors will now closely monitor margin improvement and the financial contribution from newly added hospitals over the coming quarters.
Frequently Asked Questions
Q1. Why did KIMS shares fall after Q1 FY27 results?
The stock declined as expansion-related costs reduced quarterly profit despite strong revenue growth.
Q2. How much revenue did KIMS report in Q1 FY27?
The company reported revenue from operations of ₹1,179.5 crore, up 35.3% year-on-year.
Q3. Why did KIMS' net profit decline?
Higher operating costs related to expansion and newly added hospitals weighed on profitability during the quarter.
Q4. How many operational beds does KIMS currently have?
As of June 30, 2026, the company had expanded its hospital network to 7,459 operational beds.